4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-[(4-fluorophenyl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Chemical Structure Depiction of
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-[(4-fluorophenyl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-[(4-fluorophenyl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Compound characteristics
Compound ID: | L309-1319 |
Compound Name: | 4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-[(4-fluorophenyl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide |
Molecular Weight: | 472.49 |
Molecular Formula: | C22 H21 F N4 O5 S |
Smiles: | C1CC(C1)c1nc(CN2C(COc3ccc(cc23)S(NCc2ccc(cc2)F)(=O)=O)=O)no1 |
Stereo: | ACHIRAL |
logP: | 2.8577 |
logD: | 2.8575 |
logSw: | -3.4585 |
Hydrogen bond acceptors count: | 11 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 99.018 |
InChI Key: | FDDANKCDFLPNGP-UHFFFAOYSA-N |